#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal squamous cell carcinoma stage II Chronic myeloid leukaemia (in remission) Post transplant lymphoproliferative disorder Myeloproliferative neoplasm Warm autoimmune haemolytic anaemia Craniocerebral injury Paget's disease of the vulva Keratosis follicular Pleomorphic leiomyosarcoma Juvenile idiopathic arthritis Arterial disorder Round cell liposarcoma Haemophilia B with anti factor IX Dementia Fragile X syndrome More trials…

    Learn about Rare Diseases

    Alveolar rhabdomyosarcoma – Life with Disease Pulmonary fibrosis – Treatment Alagille syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Treatment Inclusion body myositis – Life with Disease SAPHO syndrome – Life with Disease Krabbe’s disease – Diagnostics Behcet’s syndrome – Basic Information Mantle cell lymphoma stage IV Combined immunodeficiency – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BW-20805 Ly3871801 Magnesium Citrate Palopegteriparatide Mepivacaine Hydrochloride Mavacamten Posaconazole ANTIMETABOLITES Polatuzumab Vedotin Nesolicaftor DAPIGLUTIDE Enfortumab Vedotin Eo2318 Indacaterol Maleate Baxdrostat Bms-986408 Atezolizumab Darbepoetin Alfa Haemophilus Influenzae Tisotumab Vedotin More therapies…

    Learn about Your Condition

    Brain injury Ischaemic stroke Nephrolithiasis Hepatic neoplasm Colorectal cancer Macular telangiectasia Antisynthetase syndrome Choroidal dystrophy Neuralgia Peritoneal dialysis Facial paresis Rectal cancer recurrent Juvenile spondyloarthritis Paraganglion neoplasm Obstructive airways disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effect of Octreotide and Lanreotide in Peptide Receptor Radionuclide Therapy for Adults with Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Lanreotide
    • Octreotide
    The Netherlands

  • Study on Sleep and Temperature Changes in Alzheimer’s Disease for Down Syndrome Patients Using Izaflortaucipir (18F)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Trisomy 21
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Izaflortaucipir (18F)
    Spain

  • Study on Venetoclax and Epcoritamab for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Recruiting

    1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Epcoritamab
    • Venetoclax
    Belgium Denmark Germany The Netherlands

  • Study on Imatinib and Atezolizumab for Patients with Advanced Gastrointestinal Stromal Tumors After Standard Treatments Fail

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • Imatinib
    • Atezolizumab
    France

  • Study on the Effect of Arginine-Vasopressin and Noradrenaline Tartrate on Acute Kidney Injury in Liver Transplant Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute kidney injury
    • Liver transplant
    Investigated Drugs:
    • Argipressin
    • Noradrenaline Tartrate
    France

  • Study on the Safety and Effectiveness of GTAEXS617 for Patients with Advanced Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Gtaexs617
    • Bevacizumab
    • Capecitabine
    Belgium
Previous Page
1 … 565 566 567 568 569 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!